Cognoa

Cognoa's AI platform for autism diagnosis gets first FDA stamp

Cognoa has gained regulatory recognition for its machine learning software as a class II diagnostic medical device for autism -- meaning the digital health startup is now positioned to submit an appl

Cognoa Promises Worried Parents Faster Answers

There’s a lot of talk these days about computational medicine, which uses massive amounts of data to train a machine to understand even more than experts or, at least, to identify health-related p